Neil F. McFarlane, President and CEO at ZEVRA THERAPEUTICS, INC. (ZVRA), sold 14,625 shares at $8.56 ($125K) on 2026-02-09, disclosed to the SEC on 2026-02-10.
Scheduled sale ($125k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ZVRA | SELL | 2025-10-10 | $211K | — | Filing → |
| ZVRA | SELL | 2025-02-14 | $1.5M | — | Filing → |
| RTRX | SELL | 2019-05-16 | $36K | — | Filing → |